Pulse Biosciences (PLSE) shares were up 6.6% in Friday trading, a day after the company reported its Q2 results.
The company posted a Q2 net loss of $0.36 per diluted share, widening from a loss of $0.28 a year earlier.
Three analysts polled by FactSet expected a $0.36 loss.
Revenue for the quarter ended June 30 was $434,000.
Three analysts expected $500,000.
Pulse Biosciences said cash and cash equivalents totaled $101.6 million as of June 30.
Price: 40.76, Change: +2.52, Percent Change: +6.58
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments